Petros Pharmaceuticals, Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
Petros Pharmaceuticals, Inc. (PTPI) had Stock Issued During Period, Value, Restricted Stock Award, Gross of $296.00 thousand as of 2021-04-23, per its 10-K filed 2023-03-31.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross · last filed 2023-03-31
- 2021-04-23: Stock Issued During Period, Value, Restricted Stock Award, Gross $296.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross |
|---|---|
| 2021-04-23 | $296.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |